Novartis Pledges to Fight Tropical Diseases and Malaria
Swiss drugmaker Novartis has made a five-year financial commitment of $250 million to fight neglected tropical diseases (NTDs) and malaria.
Malaria
BioNTech Developing new Malaria Vaccine
BioNTech has launched a new project aimed at developing what it hopes will be a well-tolerated and highly effective malaria vaccine for the African continent. The Mainz, Germany-based company, which developed a Covid-19 vaccine together with Pfizer in only ten months, said its goal is to produce the malaria vaccine locally.
